H-AMQMLKETI-OH

Ref. 3D-PP46933

Informations sur le produit

• Nom: H-AMQMLKETI-OH
• Synonymes: NH2-Ala-Met-Gln-Met-Leu-Lys-Glu-Thr-Ile-OH

Description

Peptide H-AMQMLKETI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AMQMLKETI-OH include the following: Vaccines expressing the innate immune modulator EAT-2 elicit potent effector memory T lymphocyte responses despite pre-existing vaccine immunity YA Aldhamen , SS Seregin , NJ Schuldt - The Journal of , 2012 - journals.aai.orghttps://journals.aai.org/jimmunol/article/189/3/1349/83389 CRACC-targeting Fc-fusion protein induces activation of NK cells and DCs and improves T cell immune responses to antigenic targets YA Aldhamen , DPW Rastall, W Chen , SS Seregin - Vaccine, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X1630233X Expression of the SLAM family of receptors adapter EAT-2 as a novel strategy for enhancing beneficial immune responses to vaccine antigens YA Aldhamen , DM Appledorn , SS Seregin - The Journal of , 2011 - journals.aai.orghttps://journals.aai.org/jimmunol/article/186/2/722/84789 Role of novel type I interferon epsilon in viral infection and mucosal immunity Y Xi , SL Day, RJ Jackson, C Ranasinghe - Mucosal immunology, 2012 - nature.comhttps://www.nature.com/articles/mi201235 The MHC Class I-Restricted Immune Y Paterson, M Mata, PJ Travers, Q Liu, FR Frankel - J Immunol, 1998 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=2189bba3044af41b43b8bfb141fca41b145b024d Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses U Wille-Reece, C Wu, BJ Flynn, RM Kedl - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/12/7676/37014 Self-complementary AAVs induce more potent transgene product-specific immune responses compared to a single-stranded genome TL Wu, K Töpfer, SW Lin, H Li, A Bian, XY Zhou - Molecular Therapy, 2012 - cell.comhttps://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)30514-7 Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut SW Lin, AS Cun, K Harris-McCoy, HC Ertl - Vaccine, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X06012539 Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine SK Kanagavelu , V Snarsky, JM Termini, S Gupta - Vaccine, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X11018846 Overlapping synthetic peptides as vaccines S Jiang , R Song, S Popov, S Mirshahidi, RM Ruprecht - Vaccine, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X06005949 Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy RJ Jackson, M Worley, S Trivedi , C Ranasinghe - Vaccine, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X14011360 Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines PL Earl, C Cotter, B Moss , T VanCott, J Currier, LA Eller - Vaccine, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X09010500 Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses MO Lasaro, N Tatsis, SE Hensley, JC Whitbeck - Nature medicine, 2008 - nature.comhttps://www.nature.com/articles/nm1704 The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd M Mata, PJ Travers, Q Liu, FR Frankel - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/161/6/2985/31424 Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from M Malm, E Rollman, M Ustav, J Hinkula , K Krohn - Viral , 2005 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/vim.2005.18.678 DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane LB De Arruda, PR Chikhlikar, JT August - , 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2004.01823.x Potent T cell responses induced by single DNA vaccine boosted with recombinant vaccinia vaccine L Liu, C Qiu, Y Huang, J Xu, Y Shao - Virologica Sinica, 2013 - Springerhttps://link.springer.com/article/10.1007/s12250-013-3303-z Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant KS Korsholm, I Karlsson, ST Tang, L Brandt, EM Agger - PloS one, 2013 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063575 Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag JT Qiu , TC Chang , CT Lin, YM Chen , FQ Li, YK Soong - Vaccine, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X06009066 Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target JT Qiu , B Liu, C Tian, GN Pavlakis , XF Yu - Journal of virology, 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.74.13.5997-6005.2000 Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector JP McGettigan, S Sarma , JM Orenstein - Journal of , 2001 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.75.18.8724-8732.2001 A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag JC Fitzgerald, GP Gao , A Reyes-Sandoval - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/170/3/1416/71233 The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine J Liu, N Ngai, GW Stone, FY Yue, MA Ostrowski - Vaccine, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X09009177 Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost J Liu, M Hellerstein, M McDonnel, RR Amara , LS Wyatt - Vaccine, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X06006554 Vaccines Based on Novel Adeno-Associated Virus Vectors Elicit Aberrant CD8+ T-Cell Responses in Mice J Lin, Y Zhi, L Mays, JM Wilson - Journal of virology, 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01253-07 A new genetic vaccine platform based on an adeno-associated virus isolated from a rhesus macaque J Lin, R Calcedo, LH Vandenberghe , P Bell - Journal of , 2009 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01441-09 Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines GW Stone, S Barzee, V Snarsky, K Kee - Journal of , 2006 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.80.4.1762-1772.2006 Characterization of a single-cycle rabies virus-based vaccine vector EA Gomme, EJ Faul, P Flomenberg - Journal of , 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01870-09 Comparison of Plasmid Vaccine Immunization Schedules Using Intradermal In Vivo Electroporation D Hallengard, BK Haller, AK Maltais - Clinical and Vaccine , 2011 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/cvi.05045-11 A combination of intradermal jet-injection and electroporation overcomes in vivodose restriction of DNA vaccines D Hallengard, A Braca¥ve, M Isaguliants - Genetic vaccines and , 2012 - Springerhttps://link.springer.com/article/10.1186/1479-0556-10-5 Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles C Ranasinghe, SJ Turner , C McArthur - The Journal of , 2007 - journals.aai.orghttps://journals.aai.org/jimmunol/article/178/4/2370/75356 Unique IL-13Ralpha2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8+ T-cell avidity and protective immunity C Ranasinghe, S Trivedi , J Stambas , RJ Jackson - Mucosal immunology, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1933021922012612 Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1 C Ranasinghe, JC Medveczky, D Woltring, K Gao - Vaccine, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X06004567 Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8+ CTL avidity C Ranasinghe, IA Ramshaw - European journal of immunology, 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200838995 Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo C Li, M Hirsch , N DiPrimio , A Asokan , K Goudy - Journal of , 2009 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.00278-09 The extradomain A of fibronectin (EDA) combined with poly (I: C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria B San Roman, X De Andres, PM Muz , P Obregon - Vaccine, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X12001429 Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice AL Goldoni, M Maciel Jr, PO Rigato , O Piubelli - Immunobiology, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0171298510001543 Priming with recombinant BCG expressing novel HIV-1 conserved mosaic immunogens and boosting with recombinant ChAdOx1 is safe, stable, and elicits HIV-1 A Kilpelainen, N Saubi , N Guitart, N Moyo - Frontiers in , 2019 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2019.00923/full

• Marque: Biosynth